Am­pli­fy­Bio scoops up lab space and oth­er as­sets from PACT Phar­ma as cell ther­a­py biotech read­justs

The West Coast cell ther­a­py biotech PACT Phar­ma was fac­ing some chal­lenges af­ter sev­er­al em­ploy­ees got the axe from the com­pa­ny and ex­ecs put the ki­bosh on its on­ly clin­i­cal tri­al. Now, the com­pa­ny has sold some of its as­sets to an Ohio-based con­tract re­search or­ga­ni­za­tion.

Am­pli­fy­Bio has ac­quired a 46,280 square-foot lab in South San Fran­cis­co, CA, with around 40 em­ploy­ees spe­cial­iz­ing in cell and gene ther­a­py de­vel­op­ment and ac­cess to tech­nol­o­gy plat­forms that can be ap­plied to “prod­uct char­ac­ter­i­za­tion.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER